BLS hits top end of guidance after strong final quarter of FY26 by Steve Jones July 27, 2026July 28, 2026 Newly rebranded BLS Pharmaceuticals generated record revenue in the final quarter of the financial year as […]
News in brief: Legalise Cannabis Victoria seeks $10,000; Bioxyne confirms BLS rebrand by Adam Sheldon June 29, 2026July 2, 2026
Bioxyne to be renamed as BLS Pharmaceuticals to ‘reduce brand confusion’ by Adam Sheldon June 23, 2026June 25, 2026
Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3 by Steve Jones April 21, 2026April 21, 2026
Domestic market could ‘double’ on back of driving law reform: Bioxyne by Adam Sheldon March 25, 2026March 25, 2026
Rec-style branding risks undermining the industry, warns Bioxyne CEO by Adam Sheldon March 12, 2026March 12, 2026
Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026
